SIO 2026 Annual Scientific Meeting
2026-02-04 - 2026-02-08 | Savannah Convention Center, 1 International Dr, Savannah, GA, 31421, United States
The SIO 2026 Annual Scientific Meeting, hosted by the Society of Interventional Oncology (SIO), is scheduled for February 4-8, 2026, in Savannah, Georgia.
The event is designed to be an “education-packed extravaganza” where attendees can immerse themselves in the latest research and practices in interventional oncology (IO), discover new techniques, and network with fellow IO professionals.
A notable highlight of the meeting is the Dr. Sidney Wallace and Dr. Michael J. Wallace Distinguished Lecture, which will be presented by Afshin Gangi, MD, PhD, the Chairman of Radiology and Nuclear Medicine at the University Hospital in Strasbourg, France, and a pioneer in the field of IO.
Register.

ESMO Preceptorship on Cervical Cancer 2026: Cape Town
2026-02-05 - 2026-02-06 | Cape Town, South Africa
The ESMO Preceptorship on Cervical Cancer 2026: Cape Town is a two-day educational course focusing on providing oncologists with a thorough understanding of cervical cancer management, including screening, prevention, diagnosis, and the standard of care for early, locally advanced, recurrent, and metastatic disease. The event is scheduled for February 5–6, 2026, in Cape Town, South Africa, and is accredited with ESMO-MORA category 1 points.

ABG 34th Annual Scientific Meeting
2026-02-05 - 2026-02-07 | Pullman Melbourne On The Park, 192 Wellington Parade, Melbourne, Victoria, 3002, Australia
The Australasian Brachytherapy Group (ABG) 34th Annual Scientific Meeting will take place from February 5th to 7th, 2026, in Melbourne. The meeting will feature three keynote speakers and include a call for abstracts for both original research and case studies.
Abstract submissions are evaluated based on scientific rigor, clarity, innovation, significance, and educational value, with acceptance notifications planned for October 20, 2025. The ASM serves as a key event for professionals to discuss brachytherapy techniques, clinical outcomes, challenges, and learnings in the field.
Abstract submission.

Modernizing Oncology Endpoints: Pathways for Evidence and Policy
2026-02-05 09:30 - 14:00 (America/Halifax) | The Ritz-Carlton, Washington, D.C, 1150 22nd St NW, Washington, DC, 20037, United States
The public meeting, “Modernizing Oncology Endpoints: Pathways for Evidence and Policy,” hosted by Friends of Cancer Research, is scheduled for Thursday, February 5, 2026, from 9:30 AM to 2:00 PM ET.
This event, which will be held at The Ritz-Carlton in Washington, DC, and streamed virtually, is focused on reviewing the current landscape and application of evolving early endpoints in oncology. The meeting will explore how novel measurements, such as ctDNA and AI-based tumor assessments (including insights from Friends’ ai.RECIST and ctMoniTR Projects), can improve clinical trial efficiency, inform regulatory decision-making, and advance future policy frameworks.
Register.

15th Annual Puerto Rico Oncology Symposium 2026
2026-02-06 - 2026-02-07 | San Juan Marriott Resort and Stellaris Casino, 1309 Ashford Avenue, San Juan, 00907, Puerto Rico
The 15th Annual Puerto Rico Oncology Symposium, hosted by FLASCO and the Puerto Rico Association of Hematology and Medical Oncology, will take place on 6–7 February 2026.
This 1.5-day conference brings together students, residents, fellows, and faculty to share clinical and scientific advances in cancer care. Attendees will gain updates on treatment strategies, explore research on cancer disparities, and collaborate on best practices to improve patient outcomes across Puerto Rico and the mainland USA.

APPOS Atlanta 2026: Advanced Practice Providers Oncology Summit
2026-02-06 - 2026-02-07 | The Westin Peachtree Plaza, Atlanta, 210 Peachtree St NW, Atlanta, GA, 30303, United States
The APPOS Atlanta 2026: Advanced Practice Providers Oncology Summit is a two-day conference scheduled for February 6th – 7th at the Westin Peachtree Plaza Hotel in Atlanta, Georgia.
This premier educational event is designed to provide advanced practice providers (APPs), including NPs, PAs, pharmacists, and nurse specialists, with the latest evidence-based strategies to optimize care for cancer patients, covering topics such as updates in breast, gastric, and bladder cancers, managing the AYA patient, and cardio-oncology.
Register.

2026 Oncologic Emergency Medicine Conference
2026-02-06 - 2026-02-07 | Dan L Duncan Building, MD Anderson Cancer Center, 1155 Pressler St, Houston, TX, 77030, United States
The 2026 Oncologic Emergency Medicine Conference, hosted by The University of Texas MD Anderson Cancer Center, is a hybrid event taking place Friday, February 6, to Saturday, February 7, 2026. The in-person portion will be held at the MD Anderson – Duncan Building (1155 Pressler Street) in Houston, Texas, and will also be streamed virtually.
This conference is designed to address the knowledge gap in Oncologic Emergency Medicine, offering an interactive forum for emergency medicine professionals, nurses, pharmacists, and others to learn and apply clinical best practices for managing acute oncologic emergencies and enhancing medical decision-making for complex cancer patients in an acute care setting.
Register.

14th Asia-Pacific Breast Cancer Summit 2026
2026-02-06 - 2026-02-08 | Penang, Malaysia
The 14th Asia-Pacific Breast Cancer Summit (APBCS) 2026 will take place from February 6-8, 2026, in Penang, Malaysia. This event is the latest installment of a premier regional platform dedicated to advancing breast cancer management, building on over 13 years of collaboration and progress. The summit aims to be the region’s leading breast cancer conference, connecting global key opinion leaders and multidisciplinary experts to foster innovation and improve patient care across the Asia-Pacific region. Its overarching theme is “Reaching New Heights in Breast Cancer Care.”
The 2026 program is designed to feature rich scientific content and deepen discussions across multiple crucial areas. Key sessions planned include surgical and nursing tracks, molecular tumor boards, and in-depth regional case studies. A highly anticipated feature of the summit is the Best of SABCS Review, summarizing key takeaways from the San Antonio Breast Cancer Symposium.
The APBCS also serves as a critical forum for research, inviting participants to Submit Abstracts to highlight their innovations, with a chance to be awarded an educational grant of USD 1,500. Registration is currently open for those seeking to secure their spot and exchange knowledge, spark collaboration, and advance patient outcomes.
You can find more posts featuring APBCS 2026 on OncoDaily.

ESMO Summit Africa 2026
2026-02-06 - 2026-02-08 | Century City Conference Centre, 4 Energy Lane, Century City, Cape Town, Western Cape, 7446, South Africa
The ESMO Summit Africa 2026 is a three-day educational event focused on delivering a summary and contextual review of the most significant cancer treatment advances presented at the previous ESMO annual Congress, tailored specifically for the oncology community in Africa. Scheduled to take place in Cape Town, South Africa, from 6 to 8 February 2026, the Summit’s main objectives are to review the current standard of care for key malignancies from both a local and international perspective and to discuss current controversies in cancer management.
You can find more posts featuring ESMO on OncoDaily.

OPN New England Chapter Conference 2026
2026-02-07 | The Westin Waltham Boston, 70 Third Ave., Waltham, MA, 02451, United States
The 2026 OPN New England Chapter Conference is a single-day educational summit hosted by the Oncology Pharmacy Network, scheduled for February 7, 2026.
The event will take place at The Westin Waltham Boston in Waltham, Massachusetts, United States. It is planned for hematology/oncology pharmacy clinicians, including pharmacists, pharmacy technicians, and other healthcare professionals involved in oncology pharmacy, providing a platform for professionals in the community to network, collaborate, and share best practices to advance the field of oncology pharmacy. Attendees can earn up to 6.00 ACPE Pharmacy credits for participation in the live activity.
Register.

World Health Expo (WHX) Dubai 2026
2026-02-09 - 2026-02-12 | Dubai Exhibition Centre, Boulevard 2020 - Madinat Al Mataar - Expo City Dubai, Dubai, Dubai, United Arab Emirates
The World Health Expo (WHX) Dubai 2026 (formerly known as Arab Health) is a premier global healthcare exhibition and conference scheduled for February 9–12, 2026, primarily at the Dubai Exhibition Centre (DEC) in Dubai, United Arab Emirates.
As one of the world’s largest healthcare events, it is expected to host over 4,800 exhibitors and 270,000 professionals from 180+ countries, focusing on medical innovation, digital health, and sustainable healthcare solutions. The event runs concurrently with WHX Labs Dubai (Feb 10–13) at the Dubai World Trade Centre, together providing a comprehensive week of accredited medical conferences, networking, and technology showcases across the entire spectrum of healthcare.
Attend.

Signalling Circuits in Cancer
2026-02-10 - 2026-02-11 | Bizkaia
The European Association for Cancer Research (EACR) conference, “Signalling Circuits in Cancer,” is a Virtual Event scheduled for February 10–11, 2026. This event will focus on the fundamental mechanisms that control cancer cell signalling circuits and how they govern cancer progression and resistance to therapy.
The conference will highlight how therapy resistance is often initiated by non-genetic signalling rewiring via post-translational regulation of proteins. The educational focus is on mechanistic aspects of post-translational and transcriptional regulation, proteogenomic signal integration, and RNA biology in cancer, aiming to open novel insights for the development of new cancer therapies and diagnostics.
Register.

RWD and Digital Oncology: EBAI Framework: Evaluating AI-Based Biomarkers in Oncology 2026
2026-02-11
The Real World Data and Digital Oncology webinar, EBAI Framework: Evaluating AI-Based Biomarkers in Oncology 2026, is a virtual event that focuses on the practical application of the ESMO Basic Requirements for AI-based Biomarkers in Oncology (EBAI) framework.
The live broadcast date is 11 February 2026 at 18:30 CET. This session will explore how emerging AI-driven biomarkers can be effectively assessed, validated, and integrated into clinical decision-making.
Register.

ICISi Masterclass in Current Topics of Renal and Adrenal Imaging
2026-02-11 - 2026-02-12
The ICISi Masterclass in Current Topics of Renal and Adrenal Imaging is a live, virtual, workstation-based teaching course delivered over two half-days on February 11–12, 2026, starting at 1:00 PM.
Hosted by the International Cancer Imaging Society (ICIS), the Masterclass aims to provide a comprehensive overview and diagnostic approach for complex renal and adrenal imaging, including the evaluation of cystic and solid renal masses using the Bosniak classification, and assessing incidental and functional adrenal disorders according to current guidelines.
Attendees will benefit from mentored, hands-on, case-based learning with individual workstations and will receive a comprehensive workbook featuring the 35–40 cases reviewed, with the overall goal of providing radiologists with practical tips and key information necessary for appropriate patient management.
Register.

2026 Highlights of ASH in the Mediterranean, Middle East, and North Africa
2026-02-13 - 2026-02-14 | Hilton Istanbul Bomonti Hotel & Conference Center, Merkez, Silahşör Cd. No:42, İstanbul, Şişli, 34381, Turkey
The Highlights of ASH in the Mediterranean, Middle East, and North Africa is a two-day program co-hosted by the American Society of Hematology (ASH) and the Turkish Society of Hematology. The event will take place on February 13–14, 2026, in Istanbul, Türkiye, at the Hilton Istanbul Bomonti Hotel and Conference Center.
The program brings together global hematology leaders to discuss the most influential and novel research presented at the latest ASH Annual Meeting, covering a wide range of topics in malignant and classical hematology. Attendees can expect to connect with experts, gain insights into local and regional standards of care, and earn a Certificate of Participation.
Register.

IAPCON 2026: Continuum of Care: Hospital, Hospice and Home
2026-02-13 - 2026-02-15 | National Institute for Micro, Small, and Medium Enterprise (NI-MSME), Street No. 4, Rahmat Nagar, Yousufguda, Hyderabad, Telangana, 500045, India
The 33rd Annual International Conference of the Indian Association of Palliative Care (IAPCON 2026) will be held from 13–15 February 2026 at the National Institute for Micro, Small, and Medium Enterprises (NI-MSME) in Hyderabad, India, with pre-conference workshops on 12 February.
Organized by Sparsh Hospice and Basavatarakam Indo American Cancer Hospital and Research Institute, the conference will focus on the theme “Continuum of Care: Hospital, Hospice, and Home,” highlighting seamless and holistic palliative care across all settings. Attendees can expect keynote addresses, scientific sessions, workshops, and cultural events, fostering collaboration and the advancement of palliative care in India.

SCION Workshop 2026
2026-02-16 - 2026-02-18 | The Westin Copley Place, Boston, 10 Huntington Avenue, Boston, MA, 02116, United States
The SITC Clinical Immuno-Oncology Network (SCION) Workshop is an intimate, intensive clinical trial development program organized by the Society for Immunotherapy of Cancer (SITC), designed to address the unique challenges in designing protocols specific to cancer immunotherapy.
The 2026 SCION Workshop is scheduled for February 16-18, 2026, and will be held at The Westin Copley Place, Boston. Participation requires an application with a proposed protocol abstract and includes a mandatory 90-day post-workshop report to ensure progress in clinical trial development.

ESMO Preceptorship on Metastatic Bladder and Kidney Cancer 2026: Lugano
2026-02-18 - 2026-02-19 | Lugano, Switzerland
The ESMO Preceptorship on Metastatic Bladder and Kidney Cancer 2026: Lugano is a two-day educational course focusing on the management of metastatic bladder and kidney cancer, providing oncologists with a thorough understanding of current standards of care, molecular pathology, and novel treatment targets.
The preceptorship will take place on February 18–19, 2026, in Lugano, Switzerland, and is accredited with ESMO-MORA category 1 points. Successful applicants receive complimentary course registration and accommodation. The application deadline for this event is December 11, 2025.
Apply.

Targeted Therapies of Lung Cancer 2026
2026-02-18 - 2026-02-21 | Hyatt Regency Huntington Beach Resort And Spa, 21500 Pacific Coast Hwy, Huntington Beach, CA, 92648, United States
The Targeted Therapies of Lung Cancer (TTLC) 2026 Meeting, organized by the International Association for the Study of Lung Cancer (IASLC), is a premier event for experts dedicated to advancing lung cancer care. The meeting is scheduled to begin on February 18, 2026, and will be held in Huntington Beach, California. The conference is a must-attend event that brings together leading researchers, clinicians, and industry experts to share the latest breakthroughs in clinical research, focusing on innovation in targeted therapies for thoracic malignancies.
You can find more posts featuring IASLC on OncoDaily.

AACR IO Conference 2026
2026-02-18 08:00 - 2026-02-21 17:00 | JW Marriott Los Angeles L.A. Live, 900 W Olympic Blvd, Los Angeles, CA, Los Angeles, 90015, United States
The AACR IO Conference 2026, titled Discovery and Innovation in Cancer Immunology: Revolutionizing Treatment through Immunotherapy, will take place from February 18–21, 2026, at JW Marriott Los Angeles L.A. Live.
Led by Scientific Committee Chairs Nina Bhardwaj and Antoni Ribas, the event will focus on cutting-edge research in cancer immunology, highlighting breakthroughs in immuno-oncology (IO) drugs, inflammatory modulators, vaccines, and cellular therapies.
Building on the success of AACR IO 2025, which drew over 600 participants, AACR IO 2026 promises a comprehensive program including keynote lectures, symposia, spotlight sessions, educational content, and poster presentations. This forum offers a valuable opportunity for scientists, clinicians, industry leaders, and advocates to engage with the latest advances in cancer immunotherapy.
More posts featuring AACR.

2026 International Cancer Neuroscience Symposium
2026-02-18 08:15 - 2026-02-20 19:00 | TMC3 Collaborative Building, 7255 Helix Park Ave, Houston, TX, 77030, United States
The 2026 International Cancer Neuroscience Symposium, hosted by The University of Texas MD Anderson Cancer Center Cancer Neuroscience Program and Wiley’s Advanced Portfolio, is a three-day dynamic hybrid event scheduled for Wednesday, February 18, to Friday, February 20, 2026.
The in-person component will be held at the TMC3 Collaborative Building in Houston, Texas. This biennial symposium aims to integrate the fields of oncology, neuroscience, cancer biology, neuroimmunology, and mental health, bringing together over 30 leading international experts to share key insights and cutting-edge research to foster innovation in cancer research and enhance patient care.
Register.

2026 Multidisciplinary Head and Neck Cancers Symposium by ASTRO
2026-02-19 - 2026-02-21 | JW Marriott Desert Springs Resort and Spa, 74-855 Country Club Dr., Palm Desert, CA, 92260, United States
The 2026 Multidisciplinary Head and Neck Cancers Symposium is a two-and-a-half-day event scheduled for February 19-21, 2026. Organized by ASTRO (American Society for Radiation Oncology) and co-sponsored by other key medical societies, the symposium will be held both in-person in Palm Desert, California, and as a live virtual meeting online.
The central theme for the 2026 meeting is “Advancing Patient-Centered Care Through Innovative Team Science.” The conference aims to foster meaningful collaboration among radiation oncologists, medical oncologists, surgeons, and other specialists to share the most current, evidence-based practices in the field.
The program is structured to deliver practical insights through educational sessions, interactive case discussions, and oral abstract presentations. It serves as a forum for presenting and discussing new data, with the Call for Abstracts remaining open until October 8, 2025. The core objective of the symposium is to improve patient outcomes by advancing multidisciplinary treatment approaches and team-based care for head and neck cancers. Registration and housing are currently open for attendees.

Advocates Webinar: Modernizing Oncology Endpoints
2026-02-19 12:00 - 13:00
The Advocates Webinar: Modernizing Oncology Endpoints, hosted virtually by Friends of Cancer Research (Friends), is a free, advocates-focused session scheduled for Thursday, February 19, 2026, from 12:00 PM to 1:00 PM ET.
The webinar will build upon the public meeting held earlier in the month, focusing on translating complex scientific and policy discussions into accessible, advocacy-focused insights concerning two emerging tools in cancer drug development: circulating tumor DNA (ctDNA) and Artificial Intelligence (AI)-based tumor assessment tools. The goal is to explain how these biomarkers and technologies can accelerate evidence generation and clinical trial efficiency to support earlier patient access to treatments.
Register.

APPOS Las Vegas 2026: Advanced Practice Providers Oncology Summit
2026-02-20 - 2026-02-21 | Circa Resort & Casino, 8 Fremont St, Las Vegas, NV, 89101, United States
The APPOS Las Vegas 2026: Advanced Practice Providers Oncology Summit is a two-day continuing medical education conference organized by Horizon CME, scheduled for February 20th – 21st, 2026, at the Circa Resort and Casino in Las Vegas, Nevada.
The summit is specifically tailored for Advanced Practice Providers (APPs), including Nurse Practitioners (NPs), Physician Assistants (PAs), pharmacists, and nurses, with the primary goal of providing the latest evidence-based strategies to optimize care and outcomes for patients with cancer.
Register.

Highlights in GI Oncology
2026-02-20 - 2026-02-21 | Orlando World Center Marriott, 8701 World Center Dr, Orlando, FL, 32821, United States
The Highlights in GI Oncology conference, hosted by Horizon CME, is a two-day educational program providing the latest science and practice-changing advances from the world’s premier GI oncology event, the ASCO Gastrointestinal Cancers Symposium.
The CME initiative, designed for a multidisciplinary audience including oncologists, surgeons, and nurses, is scheduled for February 20–21, 2026, at the Orlando World Center Marriott. Expert faculty will review the most recent research and treatment strategies for various GI cancers, including colorectal, pancreatic, biliary, and neuroendocrine cancers, applying the findings to patient case contexts.
Register.

Oncology APP Leadership Forum 2026
2026-02-20 - 2026-02-21 | Circa Resort & Casino, 8 Fremont St, Las Vegas, NV, 89101, United States
The Oncology APP Leadership Forum 2026 is the 3rd annual two-day conference designed for current and aspiring Advanced Practice Provider (APP) leaders, managers, administrators, and directors in oncology.
Scheduled for February 20–21, 2026, at the Circa Resort and Casino in Las Vegas, the forum focuses on equipping APP leaders with the knowledge and skills to become more effective leaders in their organizations. Key topics on the agenda include critical conversations in the workplace, utilizing AI in leadership, constructing an APP billing dashboard, building leadership education frameworks, and a workshop on burnout and boundary setting.
Register.

16th World ADC London
2026-02-23 - 2026-02-26 | ExCeL London, One Western Gateway, Royal Victoria Dock, London, E16 1XL, United Kingdom
﻿The 16th World ADC London, set to convene at ExCeL London from February 23–26, 2026, stands as Europe’s premier conference dedicated to Antibody-Drug Conjugates (ADCs). The central focus of the 2026 event is differentiation across the ADC value chain – from design to production – in response to the dominance of Topo1 and MMAE payloads and the rising threat of resistance.
The summit will host over 800 senior European ADC decision-makers, including biopharma executives, clinicians, investors, and regulators. The comprehensive agenda features five streams covering the entire lifecycle of ADCs, specifically highlighting novel cytotoxic and non-cytotoxic payloads, dual/bispecific ADCs, non-antibody conjugates, and strategies for advancing these targeted therapies into earlier-line oncology treatments for maximum patient impact.
The 16th World ADC London event is expected to feature 800+ ADC Industry Attendees representing 240+ Companies in the Room, with presentations delivered by a 120+ Global Speaker Faculty. The agenda includes 14+ Hours of Networking, offering comprehensive One-on-One Partnering and informal networking opportunities, spread across 4 Days of ADC Insights. The content is organized into 5 Tracks of End-to-End ADC Content.
View the 2026 agenda here.
Registration link.
Full Event Guide link.
You can find more posts on ADCs on OncoDaily.

Next Generation Immunotherapies: From Innovative Approaches to Overcoming Resistance and Beyond
2026-02-24 - 2026-02-25 | Bizkaia
The Next Generation Immunotherapies: From Innovative Approaches to Overcoming Resistance and Beyond is the European Association for Cancer Research’s (EACR) inaugural virtual conference on this topic, scheduled for February 24–25, 2026.
The two-day virtual summit is dedicated to showcasing cutting-edge developments in immunotherapy, spanning from basic research to clinical applications, with a strong emphasis on addressing resistance – a common challenge in current cancer treatment.
The program will feature invited talks from leading scientists on innovative therapeutic strategies, including novel NK, T, and myeloid cell therapies, mRNA therapies, cytokine targeting, and new combinatorial immune checkpoint blockade strategies.

9th CAR-TCR Summit Europe 2026
2026-02-24 - 2026-02-26 | Park Plaza Victoria London, 239 Vauxhall Bridge Road, London, Greater London (England), SW1V 1EQ, United Kingdom
The 9th CAR-TCR Summit Europe 2026 is the essential, industry-dedicated forum for next-generation cell therapy, scheduled from February 24–26, 2026, in London, UK, at the Park Plaza Victoria hotel. Organized by Hanson Wade, the summit unites developers from Europe and Asia with an end-to-end focus on accelerating clinical success by exploring cutting-edge scientific insights and practical strategies, including novel CAR, TCR, NK, and Macrophage designs, engineering to improve durability, and solutions to overcome bottlenecks in manufacturing, regulatory approval, and commercialization.
Full Event Guide Link.

Colorectal Liver Metastasis Consensus Conference
2026-02-24 - 2026-02-26 | TMC3 Collaborative Building, 7255 Helix Park Ave, Houston, TX, 77030, United States
The Colorectal Liver Metastasis Consensus Conference, based on the Danish-Zurich model, is a three-day in-person conference dedicated to advancing care, research, and building consensus for the treatment of colorectal liver metastases. Scheduled from Tuesday, February 24, to Thursday, February 26, 2026, the meeting will be held at the TMC3 Collaborative Building (7255 Helix Park Ave.) in Houston, Texas.
Hosted by The University of Texas MD Anderson Cancer Center, the primary goal is to establish guidelines for the treatment of and research related to colorectal cancer liver metastases, culminating in a consensus statement brought forth by leading experts, clinicians, and researchers in the field.
Register.
